Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation
Cardiovascular Toxicology
Oral semaglutide is the first GLP-1RA available in a tablet form, and therefore could be important in facilitating treatment intensification with GLP-1RAs and providing an alternative option for patients with a preference for oral glucose-lowering therapy to achieve better glycemic control
This means a dose of semaglutide injected intramuscularly could reach peak concentrations in the bloodstream significantly faster than the same dose injected subcutaneously
calorie-controlled) low-carbohydrate diets improve both glycemia [52-56] and hypertension, [54-56] with the studies lasting four months, [53] one year, [54] and then two years, [56] respectively
In patients with COVID-19, we should be prepared for acute hyperglycaemia (that might be exacerbated by inflammation-associated insulin resistance), and we face the need to provide appropriate glycaemic control effectively and rapidly